Morayma Ramos serves as Director of Research and Business Development at NewGen Health Group, where she leads sponsor relationships, business development initiatives, study feasibility, site selection activities, budget and contract negotiations, and strategic growth efforts. With extensive experience in clinical research operations and business development, she plays a pivotal role in expanding NewGen’s partnerships with pharmaceutical companies, biotechnology firms, and CROs while ensuring the successful execution of clinical trials. 

Mrs. Ramos specializes in developing strategic partnerships, identifying new research opportunities, and positioning NewGen Health Group as a preferred research site across multiple therapeutic areas. She works closely with sponsors and clinical teams to oversee study startup activities, feasibility assessments, patient recruitment strategies, budget negotiations, and operational planning, ensuring studies are launched efficiently and executed to the highest standards of quality and compliance. 

Her background combines clinical research coordination, regulatory compliance, business development, marketing, and executive leadership, providing a unique perspective that bridges scientific excellence with operational efficiency. She is experienced in FDA, ICH-GCP, and IRB requirements and is committed to delivering exceptional sponsor support, accelerated startup timelines, and high-performing enrollment strategies. 

As a key leader at NewGen Health Group, Mrs. Ramos has helped cultivate relationships with leading pharmaceutical sponsors and CROs while driving growth across the organization’s research portfolio. Her dedication to innovation, patient-centered research, and operational excellence has contributed to NewGen’s reputation as a trusted clinical research partner capable of delivering quality data, diverse patient populations, and strong enrollment performance. 

• Primary point of contact for sponsors, CROs, and strategic research partnerships.
• Extensive experience in feasibility assessments, site selection, and study startup.
• Skilled negotiator for budgets, contracts, and sponsor agreements.
• Strong expertise in patient recruitment, retention, and enrollment strategy.
• Deep understanding of FDA, ICH-GCP, IRB, and regulatory requirements.
• Proven ability to accelerate study activation and operational readiness.
• Experienced in cross-functional leadership and clinical trial management.
• Dedicated to delivering responsive communication, transparency, and sponsor satisfaction.
• Focused on building long-term partnerships that drive successful clinical trial outcomes.